Tumor Suppressor Activity of the EphB2 Receptor in Prostate Cancer

Abstract

Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Department of Defense, Washington Headquarters Services, Directorate for Information Operations and Reports (0704-0188), 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302. Respondents should be aware that notwithstanding any other provision of law, no person shall be subject to any penalty for failing to comply with a collection of information if it does not display a currently valid OMB control number. PLEASE DO NOT RETURN YOUR FORM TO THE ABOVE ADDRESS.

Cognition-Enhancing Drugs: Can We Say No?

“…The arms race Kinsborne describes is likelier to erode, rather than reveal, humanity's true nature. 4 His complacency at this prospect reveals a technophilic bias at the heart of Edge's inquiry: an implicit belief that certain technologies will inevitably change us rather than being changed or stopped by us.…”